As the Head of Medical Research and Development (R&D) at A.G.S.R., I am honored to lead our dedicated team in advancing the field of autologous bone marrow therapy for the treatment of incurable and chronic diseases. Our research efforts are focused on unlocking the full potential of this revolutionary treatment modality, with the ultimate goal of offering hope and relief to patients in need.
Through collaborative partnerships with leading academic institutions, medical centers, we leverage cutting-edge methodologies to push the boundaries of scientific discovery.
Our research initiatives encompass all aspects of bone marrow therapy, from basic science investigations to translational studies and clinical trials. We are committed to conducting robust preclinical studies to elucidate the mechanisms of action underlying bone marrow therapy and optimize treatment protocols for maximum efficacy and safety.
We are proud to collaborate with leading medical centers, prestigious universities, and innovative research companies, together shaping the future of healthcare and advancing scientific knowledge.
This includes investigating the properties of different types of stem cells found in bone marrow, their potential for differentiation into various cell types, and their role in tissue repair and regeneration.
These trials are conducted in collaboration with medical institutions, regulatory agencies, and are essential for demonstrating the effectiveness of the therapy and obtaining regulatory approval for its use.
Upon regulatory approval, the intervention may enter the realm of real-world application, where it is implemented into clinical practice and undergoes further evaluation through post-market surveillance to monitor its long-term safety and effectiveness.
FDA Approval
FDA Approval